Cellular pharmacology of vinca alkaloid resistance and its circumvention

Johnson, 1978, In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia, Cancer Treatment Reports, 62, 1535 Kay, 1980, Cross resistance between actinomycin D, adriamycin and vincristine in a murine solid tumor in vivo, Biochem. Pharmacol, 29, 1081, 10.1016/0006-2952(80)90176-8 Schabel, 1980, Concepts for controlling drug-resistant tumor cells, 199 Danø, 1972, Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo, Cancer Chemother. Reports, 56, 701 Kessel, 1968, Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response, Cancer Res., 28, 938 Biedler, 1970, Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies, Cancer Res., 30, 1174 Ling, 1974, Reduced permeability in CHO cells as a mechanism of resistance to colchicine, J. Cell Physiol., 83, 103, 10.1002/jcp.1040830114 Biedler, 1975, Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells, J. Natl. Cancer Inst., 55, 671, 10.1093/jnci/55.3.671 Bech-Hansen, 1976, Pleiotropic phenotype of colchicine-resistant CHO cells: Cross-resistance and collateral sensitivity, J. Cell Physiol., 88, 23, 10.1002/jcp.1040880104 Wilkoff, 1978, Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs and actinomycin D, J. Natl. Cancer Inst., 61, 1521 Beck, 1979, Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts, Cancer Res., 39, 2070 Beck, 1983, Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts, Mol. Pharmacol, 24, 485 Beck, 1983, Vinca alkaloid resistant phenotype in cultured human leukemic lymphoblasts, Cancer Treatment Reports, 67, 875 Juliano, 1976, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochim. Biophys. Acta, 455, 152, 10.1016/0005-2736(76)90160-7 Peterson, 1983, Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine, Cancer Res., 43, 222 Garman, 1982, Alterations in cell surface membranes in Chinese hamster lung cells resistant to adriamycin, Biochem. Biophys. Res. Commun., 105, 157, 10.1016/S0006-291X(82)80025-9 Meyers, 1981, Increased synthesis of a low molecular weight protein in vincristine-resistant cells, Biochem. Biophys. Res. Commun., 99, 228, 10.1016/0006-291X(81)91736-8 Baskin, 1981, Correlation of double minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells, 78, 3654 Bielder, 1980, Marker chromosome with a homogeneously staining region (HSR) in vincristine-resistant cells, 21, 292 Minor, 1975, Colchicine resistance in mammalian cell lines, J. Cell Sci., 17, 381, 10.1242/jcs.17.3.381 Danø, 1973, Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells, Biochim. Biophys. Acta, 323, 466, 10.1016/0005-2736(73)90191-0 Skovsgaard, 1978, Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells, Cancer Res., 38, 1785 Inaba, 1977, Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia, Cancer Res., 37, 4629 Inaba, 1978, Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia, Biochem. Pharmacol., 27, 2123, 10.1016/0006-2952(78)90284-8 Skovsgaard, 1978, Mechanism of cross-resistance between vincristine and daunorubicin in ehrlich ascites tumor cells, Cancer Res., 38, 4722 Inaba, 1979, Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia, Cancer Res., 39, 2200 Inaba, 1979, Enhanced efflux of actinomycin D. vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia, Cancer Lett., 8, 111, 10.1016/0304-3835(79)90003-X Inaba, 1981, Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia, Biochem. Pharmacol., 30, 1863, 10.1016/0006-2952(81)90027-7 Bender, 1982, Correlates of vincristine resistance in four murine tumor cell lines, Cancer Lett., 15, 335, 10.1016/0304-3835(82)90135-5 Yanovich, 1983, Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy, Cancer Res., 43, 4167 Tsuruo, 1981, Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil, Cancer Res., 41, 1967 Tsuruo, 1982, Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin, Biochem. Pharmacol., 31, 3138, 10.1016/0006-2952(82)90097-1 Tsuruo, 1982, Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors, Cancer Res., 42, 4730 Tsuruo, 1983, Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug, Cancer Res., 43, 808 Tsuruo, 1983, Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine, J. Pharm. Dyn., 6, 145, 10.1248/bpb1978.6.145 Stanley, 1969, Use of the liquid seintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme, Anal. Biochem., 29, 381, 10.1016/0003-2697(69)90323-6 Kelleher, 1977, Tubulin binding affinities of podophyllotoxin and colchicine analogues, Mol. Pharmacol., 13, 232 Loike, 1976, Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells, Biochemistry, 15, 5435, 10.1021/bi00670a003 Beck, 1982, Continued expression of Vinca alkaloid-resistance by CCRF-CEM cells after treatment with tunicamycin or pronase, Cancer Res., 42, 184 Debenham, 1982, DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression, Molec. Cell Biol., 2, 881, 10.1128/MCB.2.8.881 Skovsgaard, 1980, Circumvention of resistance to daunorubicin by N-acetyl-daunorubicin in Ehrlich ascites tumor, Cancer Res., 40, 1077 Goldman, 1973, Uptake of drugs and resistance, 299 Carlsen, 1976, Modulation of membrane drug permeability in Chinese hamster ovary cells, Biochim. Biophys. Acta, 455, 900, 10.1016/0005-2736(76)90059-6 Giorgi, 1981, The transport of steroids into animal cells in culture, Endocrinology, 108, 688, 10.1210/endo-108-2-688 Schwarz, 1975, Uptake of taurocholic acid into isolated rat liver cells, Europ. J. Biochem., 55, 617, 10.1111/j.1432-1033.1975.tb02199.x Slater, 1982, Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehlrich ascites cells, J. Clin. Investig., 70, 1131, 10.1172/JCI110702 Ganapathi, 1983, Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine, Cancer Res., 43, 3696 Corps, 1982, Limitations on the use of phenothiazines and local anesthetics as indicators of calmodulin function in intact cells, FEBS Lett., 138, 280, 10.1016/0014-5793(82)80461-4 Fleckenstein, 1977, Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle, Ann. Rev. Pharmacol. Toxicol., 17, 149, 10.1146/annurev.pa.17.040177.001053 Shigenobu, 1974, Verapamil blockade of slow Na+; Ca++ responses in myocardial cells, J. Pharmacol. Exptl. Ther., 190, 280 Levin, 1977, Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase, Mol. Pharmacol., 13, 690 Raess, 1980, Calmodulin activation of red blood cell (Ca2+ + Mg2+) ATPase and its antagonism by phenothiazines, Mol. Pharmacol., 18, 253 Inaba, 1981, Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with resperine, Biochem. Pharmacol., 30, 2191, 10.1016/0006-2952(81)90246-X Landry, 1981, Can calmodulin inhibitors be used to probe calmodulin effects, Biochem. Pharmacol., 30, 2031, 10.1016/0006-2952(81)90217-3 Kanaho, 1981, The affinity of various phenothiazine drugs for membranes of intact human erythrocytes and their membrane-transforming activity, Mol. Pharmacol., 20, 704 Zallakian, 1982, Multiple effects of resperpine on chromaffin-granule membranes, Biochemistry, 21, 1051, 10.1021/bi00534a035 Cauvin, 1983, Mechanisms of calcium anatagonist-induced vasodilation, Ann. Rev. Pharmacol. Toxicol., 23, 373, 10.1146/annurev.pa.23.040183.002105 Tsuruo, 1981, Prevention of vinblastine-induced cytotoxicity by ruthenium red, Biochem. Pharmacol., 30, 213, 10.1016/0006-2952(81)90080-0 Conter, 1983, Impairment by ruthenium red of anticancer drug cytotoxicity in CCRF-CEM cells, Biochem. Pharmacol., 32, 723, 10.1016/0006-2952(83)90502-6 Gustafson, 1967, Histochemical application of ruthenium red in the study of mast cell ultrastructure, Acta. Path. Microbiol. Scandinav., 69, 393, 10.1111/j.1699-0463.1967.tb03746.x